Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Unpredictable influence of human serum on antimicrobial activity of erythromycin and three oxime ether macrolides.

Literature DB >> 3569260

Unpredictable influence of human serum on antimicrobial activity of erythromycin and three oxime ether macrolides.

R N Jones, A L Barry.

Abstract

Entities: Chemical Species

Mesh：

Substances：
Leucomycins
Erythromycin

Year: 1987 PMID： 3569260 DOI： 10.1007/bf02097206

Source DB: PubMed Journal: Eur J Clin Microbiol ISSN： 0722-2211 Impact factor: 3.267

× No keyword cloud information.

9 in total

1. Standardization of a preparative ultracentrifuge method for quantitative determination or protein binding of seven antibiotics.

Authors: L R Peterson; W H Hall; H H Zinneman; D N Gerding
Journal: J Infect Dis Date: 1977-12 Impact factor: 5.226

2. Effect of human serum on inhibition of growth of Staphylococcus aureus by antimicrobial agents.

Authors: C W Stratton; M E Evans; D J Burch; H B Hawley; T A Horsman; K K Tu; L B Reller
Journal: Eur J Clin Microbiol Date: 1986-06 Impact factor: 3.267

3. Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum.

Authors: A L Barry; R N Jones; R R Packer
Journal: Antimicrob Agents Chemother Date: 1986-01 Impact factor: 5.191

Review 4. The renaissance of erythromycin.

Authors: A S Malmborg
Journal: J Antimicrob Chemother Date: 1986-09 Impact factor: 5.790

5. Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro.

Authors: M T Labro; N Amit; C Babin-Chevaye; J Hakim
Journal: Antimicrob Agents Chemother Date: 1986-07 Impact factor: 5.191

6. Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.

Authors: J Chan; B J Luft
Journal: Antimicrob Agents Chemother Date: 1986-08 Impact factor: 5.191

7. Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1).

Authors: J A Washington; W R Wilson
Journal: Mayo Clin Proc Date: 1985-03 Impact factor: 7.616

8. Erythromycin uptake and accumulation by human polymorphonuclear leukocytes and efficacy of erythromycin in killing ingested Legionella pneumophila.

Authors: M F Miller; J R Martin; P Johnson; J T Ulrich; E J Rdzok; P Billing
Journal: J Infect Dis Date: 1984-05 Impact factor: 5.226

9. In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs.

Authors: R N Jones; A L Barry; C Thornsberry
Journal: Antimicrob Agents Chemother Date: 1983-08 Impact factor: 5.191